Table 1 The relationship between circ5165 and clinical characteristics in 99 CRC patients.
From: circ5615 functions as a ceRNA to promote colorectal cancer progression by upregulating TNKS
Variable | circ5615 | p-value | |
---|---|---|---|
Low (n = 50) | High (n = 49) | ||
Sex | |||
Male | 25 | 34 | 0.0494* |
Female | 25 | 15 | |
Age | |||
>60 | 40 | 36 | 0.4417 |
≤60 | 10 | 13 | |
T stage | |||
II–III | 39 | 28 | 0.0265* |
IV | 11 | 21 | |
N stage | |||
0 | 28 | 24 | 0.4843 |
I–II | 22 | 25 | |
M stage | |||
0 | 48 | 46 | 0.6297 |
I | 2 | 3 |